We are live on ! Find out more
LEXXW

Lexaria Bioscience Warrant
LEXXW

Delisted

LEXXW was delisted on the 13th of January, 2026.

Back to rankings

4 hedge funds and large institutions have $3.5K invested in Lexaria Bioscience Warrant in 2025 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding

Funds holding: 2 → 4 (+2)

0.9% more ownership

Funds ownership: 4.26% → 5.16% (+0.9%)

23% less capital invested

Capital invested by funds: $4.54K → $3.5K (-$1.04K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HF
HRT Financial
New York
+$1.33K
2
CS
Clear Street
New York
+$12

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$208
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
1
Heights Capital Management
California
$3.3K – – –
UBS Group
2
UBS Group
Switzerland
$194 -$208 -1,771 -42%
CS
3
Clear Street
New York
$8 +$12 +100 New
HF
4
HRT Financial
New York
– +$1.33K +11,314 New

LEXXW Hedge Fund Activity: Q3 2025 in Review

4 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Lexaria Bioscience Warrant (LEXXW) for Q3 2025, worth a combined $3.5K — down 23% from $4.54K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new LEXXW positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 1 trimmed.

The largest buyer was HRT Financial, opening a new position worth an estimated $1.33K. The largest seller was UBS Group, cutting an estimated $208.

  • 4 institutional investors held Lexaria Bioscience Warrant (LEXXW) as of Q3 2025, up from 2 in Q2 2025.
  • Funds reported $3.5K of Lexaria Bioscience Warrant stock for Q3 2025, down 23% quarter-over-quarter.
  • 2 funds opened new Lexaria Bioscience Warrant positions in Q3 2025 and 0 closed out, a net change of +2 holders.
  • The largest Lexaria Bioscience Warrant buyer in Q3 2025 was HRT Financial, an estimated $1.33K added.
  • The largest Lexaria Bioscience Warrant seller in Q3 2025 was UBS Group, an estimated $208 sold.

Based on aggregated 13F filings for Q3 2025.